Dr. Christopher Rogers was featured as the Member of the Week by the Interventional Orthopedics Foundation.
Dr. Rogers is a board certified physician in both Physical Medicine & Rehabilitation (PM&R) and Regenerative Medicine. With more than 20 years of clinical experience, Dr. Rogers is one of the world’s leading experts in the field of orthopedic regenerative medicine, specializing in the non-surgical treatment of spine and joint conditions. He has developed new approaches for the treatment of tendon injuries, osteoarthritis and disc degeneration which provide safe and viable alternatives to surgery.
Congratulations to Dr. Christopher Rogers for being the Member of the Week
Below is an excerpt from the article featured on the IOF website. You can read the full article HERE:
IOF: What do you like best about the IOF conference?
Dr. Rogers: The IOF conference has a lot to offer physicians who are passionate about Regenerative Medicine; original scientific evidence, clinical practice pearls, and regulatory updates. But most of all, it’s a unique opportunity to meet the leaders in the field and catch up with old friends.
IOF: What is your best advice for physicians wanting to learn about regenerative medicine?
Dr. Rogers: Pursue excellence! Seek training in all aspects of orthopedics from experienced mentors. Attend meetings, such as IOF, to learn from those who apply their training, skills and experience to this field. Read every article and textbook you can get your hands on. Continue to develop your diagnostic and procedural skills. Never forget our main purpose is to serve our patients.
IOF: Where do you see the field of Regenerative Medicine in 5 years?
Dr. Rogers: Ten years ago, regenerative medicine was reserved for patients who had failed all other treatment options. Today it has become evident that it will become the standard of care for many aspects of orthopedic care: preventative, nonsurgical and surgical. The variety of orthobiologic treatment options will grow exponentially requiring better treatment protocol standardization, regulatory compliance and massive amounts of clinical research. New FDA approved treatments will become available, the necessity of certain surgical procedures will diminish as will the number of people who suffer from chronic orthopedic conditions.